Synthesis and muscarinic M3 pharmacological activities of 1-azabicyclo[2.2.2]octan-3-one oxime derivatives
摘要:
A series of 1-azabicyclo[2.2.2]octan-3-one oximes and related 1-azabicyclo-[2.2.2]-octan-3-one hydroxylamines were synthesized and tested for muscarinic M(3) activity. All compounds showed at least some muscarinic binding properties, however, only one member of the series demonstrated mucarinic M(3) agonistic properties in vitro (contraction of guinea pig ileum) and in vivo (mydriasis, salivation). In addition, this compound partially reversed the cognitive deficit induced by central cholinergic depletion in two procedures testing memory in the rat, namely the delayed matching to position and swim maze tasks of spatial memory in the rat.
Synthesis and muscarinic M3 pharmacological activities of 1-azabicyclo[2.2.2]octan-3-one oxime derivatives
摘要:
A series of 1-azabicyclo[2.2.2]octan-3-one oximes and related 1-azabicyclo-[2.2.2]-octan-3-one hydroxylamines were synthesized and tested for muscarinic M(3) activity. All compounds showed at least some muscarinic binding properties, however, only one member of the series demonstrated mucarinic M(3) agonistic properties in vitro (contraction of guinea pig ileum) and in vivo (mydriasis, salivation). In addition, this compound partially reversed the cognitive deficit induced by central cholinergic depletion in two procedures testing memory in the rat, namely the delayed matching to position and swim maze tasks of spatial memory in the rat.
Azabicyclo and azacyclo oxime and amine cholinergic agents and pharmaceutically acceptable salts thereof
申请人:WARNER-LAMBERT COMPANY
公开号:EP0445731B1
公开(公告)日:1996-01-10
Synthesis and muscarinic M3 pharmacological activities of 1-azabicyclo[2.2.2]octan-3-one oxime derivatives
作者:Ralf Plate、Marc J.M. Plaum、Thijs de Boer、John S. Andrews
DOI:10.1016/0968-0896(96)00035-1
日期:1996.2
A series of 1-azabicyclo[2.2.2]octan-3-one oximes and related 1-azabicyclo-[2.2.2]-octan-3-one hydroxylamines were synthesized and tested for muscarinic M(3) activity. All compounds showed at least some muscarinic binding properties, however, only one member of the series demonstrated mucarinic M(3) agonistic properties in vitro (contraction of guinea pig ileum) and in vivo (mydriasis, salivation). In addition, this compound partially reversed the cognitive deficit induced by central cholinergic depletion in two procedures testing memory in the rat, namely the delayed matching to position and swim maze tasks of spatial memory in the rat.